John Leaman

Overview

John Leaman received an average of $1M in total compensation, including $425K in salary, at IMPEL PHARMACEUTICALS between 2020 and 2021. John Leaman also received an average of $1M at SELECTA BIOSCIENCES between 2017 and 2018.

Source: SEC filings on April 26, 2022, April 29, 2019, and April 25, 2018.

Related executives

We found 14 more executives who work or worked at IMPEL PHARMACEUTICALS and SELECTA BIOSCIENCES.

Carsten Brunn

SELECTA BIOSCIENCES

Chief Executive Officer

Kevin Tan

SELECTA BIOSCIENCES

Chief Financial Officer

Adrian Adams

IMPEL PHARMACEUTICALS

Chief Executive Officer

Leonard Paolillo

IMPEL PHARMACEUTICALS

Chief Commercial Officer

Peter Traber

SELECTA BIOSCIENCES

Chief Medical Officer

Takashi Kishimoto

SELECTA BIOSCIENCES

Chief Scientific Officer

Lloyd Johnston

SELECTA BIOSCIENCES

Chief Operations Officer

Bradford Dahms

SELECTA BIOSCIENCES

Chief Financial Officer

News

You may also like